MedKoo Cat#: 462179 | Name: HM03 inhibitor
Featured New

Description:

WARNING: This product is for research use only, not for human or veterinary use.

HM03 is a potent and selective HSPA5 inhibitor. HM03 has anticancer activity.

Chemical Structure

HM03 inhibitor
HM03 inhibitor
CAS#500565-15-1

Theoretical Analysis

MedKoo Cat#: 462179

Name: HM03 inhibitor

CAS#: 500565-15-1

Chemical Formula: C26H27ClN4O2

Exact Mass: 462.1823

Molecular Weight: 462.98

Elemental Analysis: C, 67.45; H, 5.88; Cl, 7.66; N, 12.10; O, 6.91

Price and Availability

Size Price Availability Quantity
100mg USD 750.00 2 Weeks
200mg USD 1,250.00 2 Weeks
500mg USD 1,950.00 2 Weeks
1g USD 2,950.00 2 Weeks
2g USD 5,250.00 2 Weeks
Bulk Inquiry
Buy Now
Add to Cart
Related CAS #
No Data
Synonym
HM03; HM 03; HM-03; NSC130813; NSC 130813; NSC-130813; F06;
IUPAC/Chemical Name
4-((6-chloro-2-methoxyacridin-9-yl)amino)-2-((4-methylpiperazin-1-yl)methyl)phenol
InChi Key
SUSDGTMJKOGWSZ-UHFFFAOYSA-N
InChi Code
InChI=1S/C26H27ClN4O2/c1-30-9-11-31(12-10-30)16-17-13-19(4-8-25(17)32)28-26-21-6-3-18(27)14-24(21)29-23-7-5-20(33-2)15-22(23)26/h3-8,13-15,32H,9-12,16H2,1-2H3,(H,28,29)
SMILES Code
ClC1=CC=C2C(N=C(C=CC(OC)=C3)C3=C2NC4=CC(CN5CCN(C)CC5)=C(O)C=C4)=C1
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 462.98 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Sturaro C, Ruzza C, Ferrari F, Pola P, Argentieri M, Frezza A, Marzola E, Bettegazzi B, Cattaneo S, Pietra C, Malfacini D, Calò G. In vitro pharmacological characterization of growth hormone secretagogue receptor ligands using the dynamic mass redistribution and calcium mobilization assays. Eur J Pharmacol. 2024 Oct 15;981:176880. doi: 10.1016/j.ejphar.2024.176880. Epub 2024 Aug 10. PMID: 39128804. 2: Han JH, Shim H, Shin JH, Kim KS. Antagonistic Activities of Bacillus spp. Strains Isolated from Tidal Flat Sediment Towards Anthracnose Pathogens Colletotrichum acutatum and C. gloeosporioides in South Korea. Plant Pathol J. 2015 Jun;31(2):165-75. doi: 10.5423/PPJ.OA.03.2015.0036. Epub 2015 Jun 30. PMID: 26060435; PMCID: PMC4453997. 3: Anti-mucin: MAbs RT03, HTA, HM02, HM03. Hybridoma. 2000 Dec;19(6):509. doi: 10.1089/027245700750054075. PMID: 11153074. 4: Shin CY, Lee WJ, Kim DJ, Park CS, Park SH, Ko KH. Production and characterization of monoclonal antibodies against human airway mucins. Hybridoma. 1999 Oct;18(5):457-63. doi: 10.1089/hyb.1999.18.457. PMID: 10600033.